Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.
about
MsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of francisella novicida LpxE expressed in Escherichia coliExpression cloning and periplasmic orientation of the Francisella novicida lipid A 4'-phosphatase LpxF.Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.DNA and RNA-based vaccines: principles, progress and prospects.Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.Adjuvant activity of emulsan, a secreted lipopolysaccharide from acinetobacter calcoaceticusBoosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid.Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathwaysCationic microparticles: A potent delivery system for DNA vaccinesTechnologies for enhanced efficacy of DNA vaccines.Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccinesMechanisms of action of adjuvantsComparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.
P2860
Q30840136-868E48C3-4A43-4D14-B24A-D3633D0EC111Q33233454-2D55369D-DB66-490B-B3F6-05B904DCD760Q33591055-8F86D427-B05B-4C2D-89CE-D348A51C24BDQ33783789-B23D5664-90A8-4BC4-9ED3-9D8CFBE3F223Q33784161-226C2E71-AE11-48F4-83E2-C2198996BED7Q34173229-36662027-5202-4AA5-8AA2-06CB67A7FA03Q34231216-F4DFB0DD-80B3-4559-BDC1-ED5744BBC1CBQ34703643-BF7FDE54-D096-474F-8DDD-868059F4A356Q34978592-D0D50EDE-B5D6-4643-96C9-140BE456B859Q35802958-EA15F20A-1D2E-4DCC-A533-B900737DBBB8Q36680084-45ACFF27-DE60-4E0D-B080-65E65042A54CQ36780146-B151BFF7-A9C7-46B5-9DF8-6EED57EA6546Q37109519-5A866429-2E7F-4B03-8C83-859A9F9D399EQ37156758-410C3A88-6CC4-4BE2-9F23-BC914AF96ABEQ38110539-49D72F7C-5C06-459B-890E-8A5E9D62D9C1Q39570111-30D510BF-CD18-4910-857C-E3BEDE298D64Q51575029-0900364C-945B-44A4-B23E-FA630840DE40
P2860
Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1.
@ast
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1.
@en
type
label
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1.
@ast
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1.
@en
prefLabel
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1.
@ast
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1476
Monophosphoryl lipid A enhance ...... immunodeficiency virus type 1
@en
P2093
Fukushima J
Hamajima K
Nishioka K
P2860
P304
P407
P577
1997-09-01T00:00:00Z